Global Molecular Breeding Market to Reach $7.1 Billion by 2027

Abstract: - Global Molecular Breeding Market to Reach $7. 1 Billion by 2027. - Amid the COVID-19 crisis, the global market for Molecular Breeding estimated at US$2. 4 Billion in the year 2020, is projected to reach a revised size of US$7.

New York, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Molecular Breeding Industry" - https://www.reportlinker.com/p06032264/?utm_source=GNW
1 Billion by 2027, growing at a CAGR of 16.7% over the analysis period 2020-2027. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is projected to record a 17.3% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the QTL Mapping segment is readjusted to a revised 16.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $711.2 Million, While China is Forecast to Grow at 16.1% CAGR
- The Molecular Breeding market in the U.S. is estimated at US$711.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 16.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.9% and 14.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.
- Marker-Assisted Backcrossing (MABC) Segment to Record 15.4% CAGR
- In the global Marker-Assisted Backcrossing (MABC) segment, USA, Canada, Japan, China and Europe will drive the 15.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$344.6 Million in the year 2020 will reach a projected size of US$926.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$852.2 Million by the year 2027.

- Select Competitors (Total 32 Featured) -

• Eurofins Scientific

• Illumina

• LGC Limited

• Thermo Fisher Scientific, Inc.

• SGS SA

• DanBred

• Intertek Group Plc

• LemnaTec GmbH

• Charles River Laboratories

• Slipstream Automation

• Fruitbreedomics

Read the full report: https://www.reportlinker.com/p06032264/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Molecular Breeding
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Molecular Breeding by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Molecular Breeding by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Marker-Assisted
Selection (MAS) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Marker-Assisted Selection
(MAS) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Marker-Assisted
Selection (MAS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for QTL Mapping by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for QTL Mapping by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for QTL Mapping by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Marker-Assisted
Backcrossing (MABC) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Marker-Assisted
Backcrossing (MABC) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Marker-Assisted
Backcrossing (MABC) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Genomic Selection
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Genomic Selection by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Genomic Selection by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other Processes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Other Processes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Other Processes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Single Nucleotide
Polymorphism (SNP) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Single Nucleotide
Polymorphism (SNP) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Single Nucleotide
Polymorphism (SNP) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Simple Sequence
Repeats (SSR) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 23: World Historic Review for Simple Sequence Repeats
(SSR) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Simple Sequence Repeats
(SSR) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Crop Breeding by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Crop Breeding by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Crop Breeding by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Livestock by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Livestock by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Livestock by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Molecular Breeding
by Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Molecular Breeding by Process -
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Molecular Breeding
by Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Molecular Breeding by Marker -
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Molecular Breeding
by Application - Crop Breeding and Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 39: USA 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

CANADA
Table 40: Canada Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 48: Canada 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 57: Japan 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

CHINA
Table 58: China Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 66: China 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

EUROPE
Table 67: Europe Current & Future Analysis for Molecular
Breeding by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Molecular Breeding by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Molecular Breeding by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 78: Europe 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

FRANCE
Table 79: France Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 87: France 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

GERMANY
Table 88: Germany Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 96: Germany 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

ITALY
Table 97: Italy Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: Italy Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 105: Italy 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 106: UK Current & Future Analysis for Molecular Breeding
by Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Molecular Breeding by Process -
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Molecular Breeding
by Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Molecular Breeding by Marker -
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Molecular Breeding
by Application - Crop Breeding and Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 114: UK 15-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 115: Rest of Europe Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 116: Rest of Europe Historic Review for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 117: Rest of Europe 15-Year Perspective for Molecular
Breeding by Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 118: Rest of Europe Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 119: Rest of Europe Historic Review for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 120: Rest of Europe 15-Year Perspective for Molecular
Breeding by Marker - Percentage Breakdown of Value Sales for
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) for the Years 2012, 2020 & 2027

Table 121: Rest of Europe Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 122: Rest of Europe Historic Review for Molecular
Breeding by Application - Crop Breeding and Livestock Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 123: Rest of Europe 15-Year Perspective for Molecular
Breeding by Application - Percentage Breakdown of Value Sales
for Crop Breeding and Livestock for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 124: Asia-Pacific Current & Future Analysis for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 125: Asia-Pacific Historic Review for Molecular Breeding
by Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 126: Asia-Pacific 15-Year Perspective for Molecular
Breeding by Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2012, 2020 & 2027

Table 127: Asia-Pacific Current & Future Analysis for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 128: Asia-Pacific Historic Review for Molecular Breeding
by Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 129: Asia-Pacific 15-Year Perspective for Molecular
Breeding by Marker - Percentage Breakdown of Value Sales for
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) for the Years 2012, 2020 & 2027

Table 130: Asia-Pacific Current & Future Analysis for Molecular
Breeding by Application - Crop Breeding and Livestock -

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032264/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001